dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Traversi, Letizia |
dc.contributor.author | Miravitlles Fernández, Marc |
dc.contributor.author | Shteinberg, Michal |
dc.contributor.author | Bossios, Apostolos |
dc.contributor.author | Dimakou, Katerina |
dc.contributor.author | Polverino, Eva |
dc.contributor.author | Martinez-Garcia, Miguel Angel |
dc.date.accessioned | 2022-06-28T11:00:59Z |
dc.date.available | 2022-06-28T11:00:59Z |
dc.date.issued | 2021-10-01 |
dc.identifier.citation | Traversi L, Miravitlles M, Martinez-Garcia MA, Shteinberg M, Bossios A, Dimakou K, et al. ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group. ERJ Open Res. 2021 Oct 1;7(4):00399–2021. |
dc.identifier.issn | 2312-0541 |
dc.identifier.uri | https://hdl.handle.net/11351/7744 |
dc.description | Consensus; COPD; Clinical practice |
dc.description.abstract | Introduction The coexistence of COPD and bronchiectasis seems to be common and associated with a worse prognosis than for either disease individually. However, no definition of this association exists to guide researchers and clinicians.
Methods We conducted a Delphi survey involving expert pulmonologists and radiologists from Europe, Turkey and Israel in order to define the “COPD– [bronchiectasis] BE association”.
A panel of 16 experts from EMBARC selected 35 statements for the survey after reviewing scientific literature. Invited participants, selected on the basis of expertise, geographical and sex distribution, were asked to express agreement on the statements. Consensus was defined as a score of ≥6 points (scale 0 to 9) in ≥70% of answers across two scoring rounds.
Results 102 (72.3%) out of 141 invited experts participated in the first round. Their response rate in the second round was 81%. The final consensus definition of “COPD–BE association” was: “The coexistence of (1) specific radiological findings (abnormal bronchial dilatation, airways visible within 1 cm of pleura and/or lack of tapering sign in ≥1 pulmonary segment and in >1 lobe) with (2) an obstructive pattern on spirometry ([forced expiratory volume in 1 s] FEV1/[forced vital capacity] FVC <0.7), (3) at least two characteristic symptoms (cough, expectoration, dyspnoea, fatigue, frequent infections) and (4) current or past exposure to smoke (≥10 pack-years) or other toxic agents (biomass, etc.)”. These criteria form the acronym “ROSE” (Radiology, Obstruction, Symptoms, Exposure).
Conclusions The Delphi process formulated a European consensus definition of “COPD–BE association”. We hope this definition will have broad applicability across clinical practice and research in the future. |
dc.language.iso | eng |
dc.publisher | European Respiratory Society |
dc.relation.ispartofseries | ERJ Open Research;7(4) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Malalties obstructives |
dc.subject | Bronquièctasi |
dc.subject | Enquestes |
dc.subject.mesh | Delphi Technique |
dc.subject.mesh | Bronchiectasis |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive |
dc.title | ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1183/23120541.00399-2021 |
dc.subject.decs | técnica Delfos |
dc.subject.decs | bronquiectasia |
dc.subject.decs | enfermedad pulmonar obstructiva crónica |
dc.relation.publishversion | http://dx.doi.org/10.1183/23120541.00399-2021 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Traversi L] Dept of Medicine and Surgery, Respiratory Diseases, Università dell’Insubria, Varese-Como, Italy. Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias, Barcelona, Spain. [Martinez-Garcia MA] CIBER de Enfermedades Respiratorias, Barcelona, Spain. Respiratory Dept, La Fe University and Polytechnic Hospital, Valencia, Spain. [Shteinberg M] Pulmonology Institute and Cystic Fibrosis Center, Carmel Medical Center, and the Technion – Israel Institute of Technology, the B. Rappaport Faculty of Medicine, Haifa, Israel. [Bossios A] Dept of Respiratory Medicine and Allergy, Karolinska University Hospital and Dept of Medicine, Karolinska Institutet, Stockholm, Sweden. [Dimakou K] 5th Respiratory Department, “SOTIRIA” Hospital for Chest diseases, Athens, Greece. [Polverino E] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 34820447 |
dc.identifier.wos | 000769759500037 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |